Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-10-12, Stock:JNJ, The news for the past five days is as follows:
2021-10-05: NEWS1: 'If you’re not vaccinated, get vaccinated': Doctor.NEWS2: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS3: Xencor (XNCR) Inks Deal With J&J for B-Cell Malignancy Treatment.NEWS4: Positive news on COVID-19 vaccines and treatments in the U.S. weighs against Russia’s latest record one-day death toll.NEWS5: NIH Chief Francis Collins to resign, AstraZeneca seeks COVID treatment authorization.NEWS6: US STOCKS-Wall Street gains as Big Tech bounces from selloff.NEWS7: Johnson & Johnson Asks FDA to Authorize Covid-19 Booster.NEWS8: Xencor Inks Collaboration and License Agreement with Janssen; Shares Rise.NEWS9: Johnson & Johnson Sends Booster Data to FDA. Here’s What Comes Next..NEWS10: US STOCKS-Futures up as Big Tech bounces from selloff; cyclicals rise.NEWS11: The Zacks Analyst Blog Highlights: Johnson & Johnson, Alibaba, Netflix, Qualcomm and Enbridge.NEWS12: The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout.NEWS13: UPDATE 2-J&J files for authorization of COVID-19 vaccine booster.NEWS14: J&J amends FDA EUA submission for COVID-19 booster with data showing 94% protection against moderate to severe illness.NEWS15: Johnson & Johnson Announces Submission of Emergency Use Authorization Amendment to the U.S. FDA to Support Booster of its Single-Shot COVID-19 Vaccine.NEWS16: Here's What to Do When a Stock You Own Sparks Controversy.NEWS17: J&J Gains on Seeking FDA Nod for Covid Booster for Adults.NEWS18: PepsiCo, Facebook And J&J Rise Premarket; Lordstown Motors Slumps.NEWS19: Johnson & Johnson Seeks Formal FDA Approval For COVID Booster Shot.
2021-10-06: NEWS1: Mixing & matching covid boosters ‘might be a great opportunity’: Doctor.NEWS2: Allowing people to mix COVID-19 vaccines could cut into Pfizer and Moderna’s revenue next year.NEWS3: Janssen Announces Novel Mechanism of Action that Shows Promise Against Dengue in Data Published in Nature.NEWS4: Moderna (MRNA) Gets EMA Authorization for SpikeVax Third Dose.NEWS5: J&J (JNJ) Seeks FDA Authorization for COVID-19 Booster Jab.NEWS6: Shares of Vaccine Makers Continue to Reel Under Merck’s Covid Drug Potential.NEWS7: The Energy Price Surge Is Spiraling Into Other Markets.NEWS8: J & J Applies for Emergency Use Authorization for COVID-19 Booster.NEWS9: J & J Applies for Emergency Use Authorization for COVID-19 Booster.NEWS10: Where can Investors Find Value in a Well-Rounded Company like Johnson & Johnson (NYSE:JNJ).
2021-10-07: NEWS1: Booster discussion 'a bit convoluted': Doctor.NEWS2: 'Administrative hurdles' could delay pediatric vaccine distribution: Doctor.NEWS3: 'Vaccine mandates are proving to work’: Doctor on Covid-19.NEWS4: 10 Dividend Stocks to Increase Your Monthly Income.NEWS5: What Do Mix-and-Match Doses Mean for Vaccine Stocks?.
2021-10-08: NEWS1: Studies claim Pfizer vaccine is less effective after a few months.NEWS2: Covid-19 Vaccine Boosters Are Outpacing First Doses. What Vaccine Stocks Are Doing..NEWS3: Covid-19 Vaccine Boosters Now Outpace First Doses, CDC Data Show.NEWS4: Johnson & Johson Asks FDA for Wider Use of Juvenile Arthritis Drug.NEWS5: 10 Boring Stocks That Make Money.NEWS6: 10 Best Big Pharma Stocks to Buy Now.NEWS7: COVID Update: Vaccine Booster Shots, Alternate Treatments Wrap Up.
2021-10-11: NEWS1: International SOS SVP details where doctors have been needed most.NEWS2: Johnson & Johnson to Participate in the Credit Suisse 30th Annual Healthcare Conference.NEWS3: Coronavirus: Doctor quotes Yogi Berra to urge everyone to 'let the data sort itself out'.NEWS4: J&J (JNJ) Seeks Stelara Label Expansion in Juvenile Arthritis.NEWS5: What Lies Ahead for Dow ETFs in Q3 Earnings?.NEWS6: Merck seeks emergency authorization for COVID pill.

Answer: Decrease